According to a new report by Polaris Market Research, the global cell isolation/cell separation market is valued at USD 5.81 billion in 2026 and is projected to reach USD 15.27 billion by 2034, expanding at a CAGR of 12.8% from 2026 to 2034. Growth is being driven by demand for precise cell sorting in research and clinical applications, advances in centrifugation and microfluidics, and rising investment in biotechnology and personalized medicine.
Demand is climbing as biotechnology and medical research require higher-purity, efficient, and scalable cell separation workflows. Polaris Market Research highlights the expansion of instrument suppliers and service providers, while innovations in automation and separation techniques improve efficiency, accuracy, and scalability. The market also benefits from growing research investment in personalized medicine, regenerative medicine, and stem cell research, although high technology costs and regulatory variability remain challenges.
Automation is improving the ability of laboratories and clinical workflows to process multiple samples efficiently. The report highlights technologies such as RoboSep that reduce processing time and enable simultaneous sample separation while limiting contamination.
Emerging approaches include acoustofluidic separation, droplet microfluidics for single-cell isolation, integrated on-chip isolation and analysis, large-volume microfluidic sorting, and renewed use of dielectrophoresis and magnetophoresis. These approaches are expanding the technical possibilities for research and clinical samples.
The growing use of cell-based therapies and personalized medicine is increasing the importance of precise, viable cell isolation. Closed and automated systems can support sterile processing and improve consistency in advanced therapeutic workflows.
Polaris Market Research segments the market across the categories below, providing a structured view of demand, leading segments, and areas of future opportunity.
The market includes consumables such as reagents and kits, beads, and disposables, as well as instruments including magnetic-activated cell separation systems, filtration systems, centrifuges, and flow cytometers. The instruments segment is expected to grow significantly due to technological advancements in separation techniques and improved centrifugation machines.
Read More @ https://www.polarismarketresearch.com/industry-analysis/global-cell-isolation-cell-separation-market
The market covers centrifugation, surface-marker-based separation, and filtration. Centrifugation is projected to dominate through 2034 because it separates cells based on density and can enable high-purity isolation of specific cell types.
Applications include biomolecule isolation, therapeutics, cancer research, in vitro diagnostics, and stem cell research. The market also covers human cells, including differentiated and stem cells, as well as animal cells.
End users include academic and research laboratories, cell banks, biotechnology and biopharmaceutical companies, and hospitals and diagnostics laboratories. North America held the largest revenue share in 2024, while Asia Pacific is forecast to register substantial CAGR growth as investment in academic institutes and research centers expands.
End users include academic and research laboratories, cell banks, biotechnology and biopharmaceutical companies, and hospitals and diagnostics laboratories. North America held the largest revenue share in 2024, while Asia Pacific is forecast to register substantial CAGR growth as investment in academic institutes and research centers expands.
Major players include Thermo Fisher Scientific, Inc., BD Biosciences, Beckman Coulter, Inc., Merck & Company, GE Healthcare, STEMCELL Technologies Inc., Terumo BCT, Bio-Rad Laboratories Inc., PluriSelect Life Sciences, Sigma-Aldrich Corporation, Clontech Laboratories, and Miltenyi Biotec. Recent developments include Thermo Fisher’s June 2024 launch of the Gibco CTS DynaCellect Magnetic Separation System, Applied Cells’ May 2024 MARS Ingenuity Reagent kits, and LevitasBio’s LeviCell EOS system.
For biotechnology companies, diagnostics providers, research institutions, cell therapy developers, and investors, the report provides market sizing and segmentation across products, techniques, cell types, applications, end users, and regions. These insights can support technology selection, R&D planning, commercialization, and regional expansion.
More Trending Latest Reports By Polaris Market Research:
Voice and Speech Recognition Market
Artificial Intelligence Market
G-Protein Coupled Receptors Market
| No comments yet. Be the first. |
